Hadassah

Unraveling Mysteries of the Heart

Thursday, Apr 23 2015

Mr. G., an elderly history teacher, had a heart attack many years ago and now shows very significant signs of heart failure.

Because he underwent bypass surgery a few years back, there was a prohibitive risk in his undergoing cardiac surgery. Still, his leaking mitral valve needed to be repaired. The medical team at Hadassah Medical Organization’s (HMO) Heart Institute decided to handle the repair in a less invasive way. They took Mr. G to the catheterization laboratory and, without opening his chest, repaired the valve using a device called MitraClip. “We succeeded in reducing the leakage significantly,” relates Dr. Ronen Beeri, Director of the Institute’s Cardiovascular Research Center. He adds: “We are now a month after the procedure and Mr. G. is feeling much better, able to walk around his village and planning to resume teaching.”

At HMO’s Heart Institute, physician/researchers are unraveling mysteries of the heart that result in clinical challenges, asking: What are the mechanisms through which a person’s heart valve narrows? What are the pathways through which arteries become blocked with cholesterol? Why does the heart remodel itself following a heart attack to the detriment of its own functionality?

These are the questions being investigated in the institute’s Cardiovascular Research Center. 
Although this is the basic science research arm of the Institute, explains Dr. Beeri, “We are not a pure research laboratory. We are finding solutions to problems arising from the patient’s bedside.”

Dr. Beeri explains that valvular disease is a growing epidemic—particularly aortic stenosis, where the aortic valve narrows. This, he says, is partially a result of the fact that more people survive heart attacks today and therefore live longer. The idea is to trace what causes this degeneration within the valve in order to find an effective treatment.

At the same time, Hadassah’s physician/researchers are investigating correlations between infections and inflammation and the development of atherosclerosis as part of a large European Union funded study. One hypothesis being explored is that gingival (gum) infections are possibly contributing to the acceleration of atherosclerosis.

In their clinical practice, Hadassah’s doctors are seeing that following a heart attack, a patient’s heart strangely remodels itself in a way that puts the individual into heart failure. Dr. Beeri explains that aside from performing a heart transplant, they don’t really have a treatment to lift the heart out of this state of heart failure.

Working in collaboration with Dr. Robert A. Levine, senior physician in the Cardiac Ultrasound Laboratory at Massachusetts General Hospital, Dr. Beeri is trying to figure out why the heart follows this path, what cellular processes cause the cells to fail, and how to prevent this detrimental remodeling. Experiments are performed on sheep at Massachusetts General Hospital under the supervision of Dr. Levine, and Dr. Beeri, also a visiting scientist at Harvard Medical School, does the molecular analysis on samples shipped to Hadassah.

Dr. Beeri is also collaborating with Dr. Roger Hajjar, a leader in the field of cardiac gene therapy and director of the Cardiovascular Research Center at Mt. Sinai (NY) Medical Center, in using gene therapy to replace failing cells with new cells. They are taking viruses that do not elicit an immune reaction inside the body and employing them as transporters of specific genetic material into the heart cell, which will bring up calcium levels—an event necessary for healthy heart contractions. At the same time, this newly injected genetic material ensures sufficient subsequent removal of the calcium to prevent saturation of the cell, which would be damaging. In the sheep model of heart failure, researchers implanted a gene to control calcium signaling and the sheep exhibited better heart functioning and compensation.

With this technique already shown to be successful in animal models, Hadassah’s physicians recently participated in one of the first multinational trials, led by Dr. Hajjar, using this virus on patients.

Based on the chance discovery six years ago that a sheep’s left atrial appendage contains stem cells, which enable the heart to repair itself, Hadassah’s physicians are now isolating stem cells from this appendage in a dish and inducing them to differentiate into specialized cells of the heart, potentially replacing cells that were lost due to heart attacks or disease. These cells have been shown to behave like mature cardiac cells and actually contract within the dish.

Currently, Hadassah’s physicians are also implanting these stem cells into mice at the site of an infarcted area. Dr. Beeri reports that preliminary results indicate these cells do grow inside the heart muscle and become mature cardiac cells.

“The challenge in cell therapy,” he notes, “is to determine how to bring this therapy into the clinical arena.”

Another research track being explored at Hadassah is working to amplify the heart’s signaling agents that tell its cells to go to the injured site for repair. With this technique, they would be able to use the patient’s own cells to repair the heart, as opposed to transplanting foreign cells from outside the body. Hadassah’s researchers are now examining different signaling agents in a petri dish to see how they relate to heart cells that are sitting on the other side of the dish.

Looking toward the future, Dr. Beeri hypothesizes, “We may be able, in the not so far future, to induce parts of the heart to regenerate and limit the damage done by heart attacks.”

Dr. Beeri’s group also collaborates on a project, run by Prof. and Retired Israel Air Force Brigadier General Dr. Kobi Bortman from Beersheba, which aims to build a reliable computerized model of the heart. This may enable physicians to use the computer to examine the effects of a treatment or medication on a specific heart, before administering it to a patient. By the same token, he adds, “We may be able, in the not so far future, to take a CT or MRI picture of a person’s valve, model the image with a 3D printer, and then build a personalized new valve to implant in an individual’s heart.” This work is preliminary at this point, he brings out, but it “may be the next frontier in personalized medicine as it relates to cardiology.”

Comments

From: Obed L. on June 17, 2015
I ASK FOR JOIN, AND FOR OPEN THE BRANCH OF HADASSAH ORGANIZATION IN TANZANIA AND EAST AFRICAN, COLLECT WOMEN, HELP, ORPHAN, AND THOSE FAMILY REJECTED HER TOGETHER WE CAN MAKE BEST LIFE OF THE WOMEN IN TH WORLD.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Jun 20 2017

Send in the Clowns: A Hadassah UK Dispatch

This week Hadassah UK (HUK) brought in one of the Hadassah Medical Organization's best and more unusual, head medical clown David Barashi (DuSH).

READ MORE ›
alt_text

Friday, Jun 16 2017

Hadassah’s Director General Receives Honorary PhD from Cyprus Medical School

For sharing his knowledge and experience with senior officials in the Cyprus medical system, Prof. Zeev Rotstein, Director General of the Hadassah Medical Organization, was awarded an honorary PhD from the St. George University of London’s Medical Program at the University of Nicosia Medical School in Cyprus.

READ MORE ›
alt_text

Thursday, Jun 8 2017

Hadassah Doctors Discover Bullet
in 12-Year-Old’s Arm

Muhammad Baduan, age 12, had been experiencing pain in his arm on and off for months. Hadassah Hospital Ein Kerem Emergency Room physicians put an end to the boy’s pain when they solved the mystery: Muhammad had a 22-millimeter bullet hidden in that arm--a bullet that had been shot into the air as part of a post-wedding ceremony celebration.

READ MORE ›
alt_text

Monday, Jun 5 2017

Hadassah Cutting-Edge Neuropsychiatrist Keynotes Alzheimer’s Conference

“The key is to give medicines much earlier--before the brain material has been destroyed by Alzheimer’s disease,” Dr. Shahar Arzy, head of the Hadassah Medical Organization’s Computational Neuropsychiatry Laboratory, told his audience at the Alzheimer’s Foundation of America (AFA)’s New York Educational Conference on May 5, 2017.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More